dapsone has been researched along with Pyrexia in 31 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 7.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "In summary, we report a case of dapsone hypersensitivity syndrome with classical symptoms of fever, rash and multi-organ involvement including a rare manifestation of myocarditis." | 7.73 | Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis. ( Ng, V; Oh, DC; Tan, CH; Tay, YK; Teo, RY, 2006) |
| "We conclude that cholangitis, though unusual, can also form a part of dapsone syndrome." | 7.72 | Dapsone induced cholangitis as a part of dapsone syndrome: a case report. ( Choudhuri, G; Dhingra, S; Itha, S; Kumar, A, 2003) |
| "Dapsone-induced agranulocytosis is in common (1/10,000 to 1/20,000)." | 7.69 | [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis]. ( Callens, A; Gargot, S; Lorette, G; Machet, L; Mercier, E; Vaillant, L, 1996) |
| "All patients with the acquired immunodeficiency syndrome and a first episode of Pneumocystis carinii pneumonia seen at the San Francisco General Hospital between November 1984 and April 1985 were evaluated for oral treatment with dapsone (100 mg/d) plus trimethoprim (20 mg/kg body weight X d)." | 7.67 | Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. ( Hopewell, PC; Hughes, W; Leoung, GS; Mills, J; Wofsy, C, 1986) |
| "A 73-year-old man was admitted in respiratory failure that had subacutely progressed after five weeks of dapsone treatment for a skin rash." | 5.42 | Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid. ( Fukushima, K; Hayama, Y; Higashiguchi, M; Hirata, H; Inoue, K; Kida, H; Kijima, T; Kinehara, Y; Kumanogoh, A; Minami, T; Miyake, K; Morimura, O; Nagatomo, I; Takeda, Y; Takeuchi, Y, 2015) |
| "Dapsone has been shown to possess anti-inflammatory activity in a variety of animal models." | 5.26 | The anti-inflammatory profile of dapsone in animal models of inflammation. ( Gemmell, DK; Lewis, AJ; Stimson, WH, 1978) |
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 3.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "In summary, we report a case of dapsone hypersensitivity syndrome with classical symptoms of fever, rash and multi-organ involvement including a rare manifestation of myocarditis." | 3.73 | Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis. ( Ng, V; Oh, DC; Tan, CH; Tay, YK; Teo, RY, 2006) |
| "We conclude that cholangitis, though unusual, can also form a part of dapsone syndrome." | 3.72 | Dapsone induced cholangitis as a part of dapsone syndrome: a case report. ( Choudhuri, G; Dhingra, S; Itha, S; Kumar, A, 2003) |
| "Dapsone-induced agranulocytosis is in common (1/10,000 to 1/20,000)." | 3.69 | [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis]. ( Callens, A; Gargot, S; Lorette, G; Machet, L; Mercier, E; Vaillant, L, 1996) |
| "All patients with the acquired immunodeficiency syndrome and a first episode of Pneumocystis carinii pneumonia seen at the San Francisco General Hospital between November 1984 and April 1985 were evaluated for oral treatment with dapsone (100 mg/d) plus trimethoprim (20 mg/kg body weight X d)." | 3.67 | Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. ( Hopewell, PC; Hughes, W; Leoung, GS; Mills, J; Wofsy, C, 1986) |
| "A patient being treated with dapsone developed a hypersensitivity reaction with typical features of the "sulfone syndrome," including fever, malalse, and hepatitis." | 3.67 | Liver involvement in the sulfone syndrome. ( Cattau, EL; Johnson, DA; Kuritsky, JN; Zimmerman, HJ, 1986) |
| "Dapsone was discontinued in nine (39%) patients because of adverse reactions." | 2.67 | Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. ( Horowitz, HW; Jorde, UP; Wormser, GP, 1993) |
| "The treatment of neutrophilic panniculitis can be challenging." | 2.46 | Anakinra for difficult-to-treat neutrophilic panniculitis: IL-1 blockade as a promising treatment option for neutrophil-mediated inflammatory skin disease. ( Cribier, B; Foubert, A; Lipsker, D; Perrigouard, C, 2010) |
| "A 73-year-old man was admitted in respiratory failure that had subacutely progressed after five weeks of dapsone treatment for a skin rash." | 1.42 | Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid. ( Fukushima, K; Hayama, Y; Higashiguchi, M; Hirata, H; Inoue, K; Kida, H; Kijima, T; Kinehara, Y; Kumanogoh, A; Minami, T; Miyake, K; Morimura, O; Nagatomo, I; Takeda, Y; Takeuchi, Y, 2015) |
| " Once the patient's liver function normalized, prednisone dosage was reduced by 5 mg weekly." | 1.29 | Dapsone hypersensitivity syndrome. ( Prussick, R; Shear, NH, 1996) |
| "Dapsone has been shown to possess anti-inflammatory activity in a variety of animal models." | 1.26 | The anti-inflammatory profile of dapsone in animal models of inflammation. ( Gemmell, DK; Lewis, AJ; Stimson, WH, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (25.81) | 18.7374 |
| 1990's | 6 (19.35) | 18.2507 |
| 2000's | 6 (19.35) | 29.6817 |
| 2010's | 9 (29.03) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, NJ | 1 |
| Kraft, RM | 1 |
| Schouten, WM | 1 |
| Soriano, A | 1 |
| Soriano, M | 1 |
| Espinosa, G | 1 |
| Manna, R | 1 |
| Emmi, G | 1 |
| Cantarini, L | 1 |
| Hernández-Rodríguez, J | 1 |
| Mack, J | 1 |
| Mian, A | 1 |
| Gusdorf, L | 1 |
| Lipsker, D | 2 |
| Pillemer, B | 1 |
| English, JC | 1 |
| Gehris, RP | 1 |
| Kinehara, Y | 1 |
| Kijima, T | 1 |
| Inoue, K | 1 |
| Hirata, H | 1 |
| Takeuchi, Y | 1 |
| Fukushima, K | 1 |
| Hayama, Y | 1 |
| Higashiguchi, M | 1 |
| Morimura, O | 1 |
| Miyake, K | 1 |
| Minami, T | 1 |
| Nagatomo, I | 1 |
| Takeda, Y | 1 |
| Kida, H | 1 |
| Kumanogoh, A | 1 |
| Ezzedine, K | 1 |
| Malvy, D | 1 |
| Beylot, C | 1 |
| Longy-Boursier, M | 1 |
| Sheen, YS | 1 |
| Chu, CY | 1 |
| Wang, SH | 1 |
| Tsai, TF | 1 |
| Perrigouard, C | 1 |
| Foubert, A | 1 |
| Cribier, B | 1 |
| do Valle, SO | 1 |
| França, AT | 1 |
| Pires, GV | 1 |
| Guimarães, P | 1 |
| Dias, GA | 1 |
| Levy, SA | 1 |
| Lu, PH | 1 |
| Lin, YC | 1 |
| Wu, YH | 1 |
| Fett, N | 1 |
| Kovarik, C | 1 |
| Bennett, D | 1 |
| Hirahara, K | 1 |
| Kano, Y | 1 |
| Asano, Y | 1 |
| Shiohara, T | 1 |
| Itha, S | 1 |
| Kumar, A | 1 |
| Dhingra, S | 1 |
| Choudhuri, G | 1 |
| Teo, RY | 1 |
| Tay, YK | 1 |
| Tan, CH | 1 |
| Ng, V | 1 |
| Oh, DC | 1 |
| Ramos, A | 1 |
| Roustán, G | 1 |
| Angel-Moreno, A | 1 |
| Suárez, E | 1 |
| Aram, H | 1 |
| Schiff, BL | 1 |
| Kern, AB | 1 |
| Bercovitch, L | 1 |
| Risse, L | 1 |
| Bernard, P | 1 |
| Brosset, A | 1 |
| Enginger, V | 1 |
| Bedane, C | 1 |
| Bonnetblanc, JM | 1 |
| Stephen, G | 1 |
| George, O | 1 |
| Mathai, D | 1 |
| Kaur, A | 1 |
| Abraham, OC | 1 |
| Petersen, E | 1 |
| Marbiah, NT | 1 |
| Magbiti, E | 1 |
| Lines, JD | 1 |
| Maude, GH | 1 |
| Høgh, B | 1 |
| Curtis, C | 1 |
| Greenwood, B | 1 |
| Bradley, D | 1 |
| Jorde, UP | 1 |
| Horowitz, HW | 1 |
| Wormser, GP | 1 |
| Prussick, R | 1 |
| Shear, NH | 1 |
| Machet, L | 1 |
| Callens, A | 1 |
| Mercier, E | 1 |
| Gargot, S | 1 |
| Lorette, G | 1 |
| Vaillant, L | 1 |
| Permal-Griffiths, S | 1 |
| Dhôte, R | 1 |
| Delègue, P | 1 |
| Vayre, L | 1 |
| Christoforov, B | 1 |
| Lewis, AJ | 1 |
| Gemmell, DK | 1 |
| Stimson, WH | 1 |
| Leoung, GS | 1 |
| Mills, J | 1 |
| Hopewell, PC | 1 |
| Hughes, W | 1 |
| Wofsy, C | 1 |
| Wille, RC | 1 |
| Morrow, JD | 1 |
| Johnson, DA | 1 |
| Cattau, EL | 1 |
| Kuritsky, JN | 1 |
| Zimmerman, HJ | 1 |
| Hall, AP | 1 |
| Berman, SJ | 1 |
4 reviews available for dapsone and Pyrexia
| Article | Year |
|---|---|
Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.
Topics: Animals; Autoimmune Diseases; Biological Therapy; Colchicine; Dapsone; Evidence-Based Medicine; Feve | 2020 |
Neutrophilic urticarial dermatosis: A review.
Topics: Arthralgia; Colchicine; Cryopyrin-Associated Periodic Syndromes; Dapsone; Dermis; Diagnosis, Differe | 2018 |
Anakinra for difficult-to-treat neutrophilic panniculitis: IL-1 blockade as a promising treatment option for neutrophil-mediated inflammatory skin disease.
Topics: Dapsone; Female; Fever; Humans; Interleukin 1 Receptor Antagonist Protein; Middle Aged; Neutrophils; | 2010 |
[Disulone hypersensitivity syndrome].
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Fever; Humans; Middl | 1994 |
2 trials available for dapsone and Pyrexia
| Article | Year |
|---|---|
Controlled trial of lambda-cyhalothrin impregnated bed nets and Maloprim chemosuppression to control malaria in children living in a holoendemic area of Sierra Leone, west Africa. Study design and preliminary results.
Topics: Animals; Anopheles; Bedding and Linens; Child; Child, Preschool; Dapsone; Double-Blind Method; Drug | 1993 |
Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals.
Topics: Adult; AIDS-Related Opportunistic Infections; Contraindications; Dapsone; Drug Eruptions; Female; Fe | 1993 |
25 other studies available for dapsone and Pyrexia
| Article | Year |
|---|---|
27-Year-Old Woman With Fever, Headache, and Anemia.
Topics: Adult; Anemia; Anti-Infective Agents; Blood Gas Analysis; Dapsone; Female; Fever; Headache; Humans; | 2020 |
Case 5: Fever and Hypoxia in a 17-year-old Boy Undergoing Cancer Chemotherapy.
Topics: Adolescent; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Dapsone; Fever; H | 2017 |
Periodic fever with aphthous stomatitis, pharyngitis, and adenitis responsive to oral corticosteroids and dapsone.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Child; Dapsone; Female; Fever; Humans; Lymphadenitis | 2013 |
Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid.
Topics: Acute Lung Injury; Aged; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Dapsone; Diagnosis, Di | 2015 |
Autochthonous leprosy in metropolitan France presenting with a diffuse infiltration of the face and febrile illness.
Topics: Biopsy, Needle; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Facial Der | 2009 |
Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Chemical and Drug Induced Liver Injur | 2009 |
Dapsone hypersensitivity syndrome during delayed pressure urticaria treatment.
Topics: Adult; Dapsone; Dengue; Diagnosis, Differential; Drug Hypersensitivity; Erythema; Female; Fever; His | 2010 |
Relapsing polychondritis complicated with Sweet's syndrome and normolipemic neutrophilic xanthomatosis successfully treated by dapsone.
Topics: Aged; Dapsone; Dyspnea; Fever; Humans; Male; Neutrophils; Polychondritis, Relapsing; Sweet Syndrome; | 2011 |
Palisaded neutrophilic granulomatous dermatitis without a definable underlying disorder treated with dapsone.
Topics: Adult; Arthralgia; Dapsone; Dermatitis; Fever; Granuloma; Humans; Male; Neutrophils; Skin | 2011 |
Osteonecrosis of the femoral head in a patient with Henoch-Schönlein purpura and drug-induced hypersensitivity syndrome treated with corticosteroids.
Topics: Adult; Anti-Infective Agents; Dapsone; Eosinophilia; Erythema; Exanthema; Femur Head Necrosis; Fever | 2013 |
Dapsone induced cholangitis as a part of dapsone syndrome: a case report.
Topics: Adult; Cholangitis; Dapsone; Drug Eruptions; Drug Hypersensitivity; Fever; Humans; Hyperbilirubinemi | 2003 |
Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dapsone; Diagnosis, Differen | 2006 |
[Worsening of leprosy lesions in a Philippine-born patient].
Topics: Adult; Antigens, Bacterial; Dapsone; Facial Dermatoses; Fever; Humans; Leprostatic Agents; Leprosy, | 2008 |
Acute febrile neutrophilic dermatosis (Sweet's syndrome). Response to dapsone.
Topics: Acute Disease; Adult; Dapsone; Female; Fever; Humans; Leukocyte Count; Neutrophils; Skin; Skin Disea | 1984 |
Sweet's syndrome: report of two atypical cases.
Topics: Biopsy; Blood Sedimentation; Dapsone; Female; Fever; Humans; Leukocytosis; Male; Methylprednisolone; | 1982 |
Dapsone syndrome.
Topics: Adult; Dapsone; Drug Eruptions; Drug Hypersensitivity; Female; Fever; Humans; Liver; Syndrome | 1994 |
Dapsone hypersensitivity syndrome.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Chole | 1996 |
[Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
Topics: Agranulocytosis; Dapsone; Dermatitis Herpetiformis; Fever; Humans; Male; Middle Aged | 1996 |
[An Antilles fever. Dapsone allergy].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatitis Herpet | 2001 |
The anti-inflammatory profile of dapsone in animal models of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; | 1978 |
Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Bronchoscopy; Dapsone; Drug Eruptions; Drug Therapy, Combination | 1986 |
Case report: dapsone hypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.
Topics: Anemia, Hemolytic; Dapsone; Drug Hypersensitivity; Fever; Headache; Hepatitis; Humans; Male; Middle | 1988 |
Liver involvement in the sulfone syndrome.
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Fever; Humans; Liver | 1986 |
Recrudescent falciparum malaria in Vietnam.
Topics: Adult; Black People; Dapsone; Fever; Follow-Up Studies; Humans; Malaria; Male; Military Medicine; Pl | 1973 |
Chloroquine-pyrimethamine-sulfisoxazole therapy of Plasmodium falciparum malaria. An alternative to quinine.
Topics: Chloroquine; Dapsone; Drug Resistance, Microbial; Fever; Humans; Malaria; Male; Military Medicine; P | 1969 |